Technology
Health
Biotechnology

Alkermes

$24.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.19 (5.15%) Today
$0.00 (0.00%) As of 4:07 PM EDT after-hours

Why Robinhood?

You can buy or sell Alkermes and other stocks, options, ETFs, and crypto commission-free!

About ALKS

Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include the brands Aristada and Vivitrol. Read More The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Employees
2,300
Headquarters
Dublin, Dublin
Founded
2011
Market Cap
3.62B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.36M
High Today
$24.48
Low Today
$23.03
Open Price
$23.06
Volume
1.47M
52 Week High
$46.98
52 Week Low
$21.29

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Medical
Pharmaceutical
Europe (Non-UK)
Europe

ALKS News

Yahoo FinanceJun 13

See what the IHS Markit Score report has to say about Alkermes Plc.

25

ALKS Earnings

-$0.22
-$0.03
$0.15
$0.34
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 25, Pre-Market

More ALKS News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.